In collaboration with Julius Clinical, TRICALS will present the webinar: “Efficient Patient Identification in ALS Clinical Trials; Leveraging the Concept of Fast and Slow Progressors”. The webinar will take place on November 10, 2020 at 18:00 CET.
We are pleased to announce that this webinar will be presented by: Prof. Dr. Leonard van den Berg (Professor of Neurology and Chair of TRICALS) and Dr. Ruben van Eijk (Assistant Professor and Medical Statistician) from our TRICALS Centre at UMC Utrecht, the Netherlands.
Topics that will be covered, include:
- Prediction-based inclusion criteria
- Defining the concept of fast vs slow progressors
- Addressing disease heterogeneity and reduce variance
- Regulatory perspective (EMA) on prediction-based patient selection
Don’t miss this opportunity and register now by clicking the link: https://bit.ly/3oAnz2L. The webinar will be recorded, so even if you can’t make it, make sure to sign up to receive the replay!
Related news
Lighthouse II study finished recruitment phase with more than 400 participants
The Lighthouse II study finished recruiting. With currently 419 participants in the […]
Your expert opinion wanted on ALS clinical trials
TRICALS aims to improve clinical research to finding a cure for ALS. […]
European Commission approves Tofersen as treatment for ALS-SOD1
The European Commission has approved the drug QALSODY, better known as Tofersen. […]
Amylyx terminates open-label extension of the PHOENIX study
The pharmaceutical company Amylyx has announced that they will terminate the open-label […]